nach oben

Erschienen in:

27.06.2022 | Nephrology - Original Paper

High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related infection in Japanese patients undergoing peritoneal dialysis

verfasst von: Eriko Yoshida Hama, Kiyotaka Uchiyama, Tomoki Nagasaka, Ei Kusahana, Takashin Nakayama, Itaru Yasuda, Kohkichi Morimoto, Naoki Washida, Hiroshi Itoh

Erschienen in: International Urology and Nephrology | Ausgabe 12/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Obesity may negatively impact the clinical outcomes of patients undergoing peritoneal dialysis (PD). However, the impact of obesity on PD-related outcomes remains unclear. We herein examined the association of high body mass index (BMI) with complete hemodialysis (HD) transfer, transition to HD and PD/HD hybrid therapy, peritonitis, catheter exit-site and tunnel infection (ESI/TI), and heart failure-related hospitalization.

Methods

This retrospective cohort study included 120 patients who underwent PD-catheter insertion between January 2008 and June 2018. BMI ≥ 25 kg/m² at the time of PD-catheter insertion was defined as high BMI, and its association with outcomes was analyzed using the log-rank test and Cox proportional hazards models.

Results

The follow-up duration was 46.2 (23.3–75.3) months. The time until transfer to HD and hybrid therapy was significantly shorter in the high BMI group than that in the low BMI group, whereas the time until HD transfer was not significantly different between the two groups (P < 0.001 and 0.18, respectively). Peritonitis-free and ESI/TI-free survivals were significantly shorter in the high BMI group than those in the low BMI group (P = 0.006 and 0.03, respectively). After adjusting for age, sex, diabetes mellitus, and estimated glomerular filtration rate, high BMI remained a significant risk factor for transferring to HD and hybrid therapy, peritonitis, and ESI/TI (hazard ratio [HR] 2.60, P < 0.001; HR 2.08, P = 0.01; HR 2.64, P = 0.02, respectively).

Conclusion

BMI ≥ 25 kg/m² is a risk factor for transition to HD and hybrid therapy, peritonitis, and ESI/TI, but not for complete HD transfer in Japanese patients with PD.

Nur mit Berechtigung zugänglich

Nitta K, Goto S, Masakane I et al (2020) Annual dialysis data report for 2018, JSDT renal data registry: survey methods, facility data, incidence, prevalence, and mortality. Ren Replace Ther. https://doi.org/10.1186/s41100-020-00286-9CrossRef

Jaar BG, Plantinga LC, Crews DC et al (2009) Timing, causes, predictors and prognosis of switching from peritoneal dialysis to hemodialysis: a prospective study. BMC Nephrol 10:3. https://doi.org/10.1186/1471-2369-10-3CrossRefPubMedPubMedCentral

Guo A, Mujais S (2003) Patient and technique survival on peritoneal dialysis in the United States: evaluation in large incident cohorts. Kidney Int. https://doi.org/10.1046/j.1523-1755.2003.08801.xCrossRefPubMed

Huisman RM, Nieuwenhuizen MG, de Charro Th, F, (2002) Patient-related and centre-related factors influencing technique survival of peritoneal dialysis in the Netherlands. Nephrol Dial Transplant 17:1655–1660. https://doi.org/10.1093/ndt/17.9.1655CrossRefPubMed

Johnson DW, Herzig KA, Purdie DM et al (2000) Is obesity a favorable prognostic factor in peritoneal dialysis patients? Perit Dial Int 20:715–721. https://doi.org/10.1177/089686080002000623CrossRefPubMed

Aslam N, Bernardini J, Fried L, Piraino B (2002) Large body mass index does not predict short-term survival in peritoneal dialysis patients. Perit Dial Int 22:191–196. https://doi.org/10.1177/089686080202200205CrossRefPubMed

McDonald SP, Collins JF, Johnson DW (2003) Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 14:2894–2901. https://doi.org/10.1097/01.asn.0000091587.55159.5fCrossRefPubMed

Snyder JJ, Foley RN, Gilbertson DT, Vonesh EF, Collins AJ (2003) Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64:1838–1844. https://doi.org/10.1046/j.1523-1755.2003.00287.xCrossRefPubMed

Abbott KC, Glanton CW, Trespalacios FC et al (2004) Body mass index, dialysis modality, and survival: analysis of the United States renal data system dialysis morbidity and mortality wave II study. Kidney Int 65:597–605. https://doi.org/10.1111/j.1523-1755.2004.00385.xCrossRefPubMed

10.

Johansen KL, Young B, Kaysen GA, Chertow GM (2004) Association of body size with outcomes among patients beginning dialysis. Am J Clin Nutr 80:324–332. https://doi.org/10.1093/ajcn/80.2.324CrossRefPubMed

11.

de Mutsert R, Grootendorst DC, Boeschoten EW, Dekker FW, Krediet RT (2009) Is obesity associated with a survival advantage in patients starting peritoneal dialysis? Contrib Nephrol 163:124–131. https://doi.org/10.1159/000223790CrossRefPubMed

12.

Obi Y, Streja E, Mehrotra R, Rivara MB, Rhee CM, Soohoo M et al (2018) Impact of obesity on modality longevity, residual kidney function, peritonitis, and survival among incident peritoneal dialysis patients. Am J Kidney Dis 71:802–813. https://doi.org/10.1053/j.ajkd.2017.09.010CrossRefPubMed

13.

Shibagaki Y, Faber MD, Divine G, Shetty A (2002) Feasibility of adequate solute clearance in obese patients on peritoneal dialysis: a cross-sectional study. Am J Kidney Dis 40:1295–1300. https://doi.org/10.1053/ajkd.2002.36904CrossRefPubMed

14.

Yoshiike NWN, Matsushima S, Ito C et al (2000) Obese degree and diabetes, hypertension based on body mass index, epidemiological examination - by associated - multicenter study with the risk factor of hyperlipidemia. J Japan Soc Study Obes 6:4–17

15.

Kawanishi H, Marshall MR, Zhao J et al (2021) Mortality, hospitalization and transfer to haemodialysis and hybrid therapy, in Japanese peritoneal dialysis patients. Perit Dial Int. https://doi.org/10.1177/08968608211016127CrossRefPubMed

16.

Kang SH, Cho KH, Park JW, Yoon KW, Do JY (2013) Geriatric nutritional risk index as a prognostic factor in peritoneal dialysis patients. Perit Dial Int 33:405–410. https://doi.org/10.3747/pdi.2012.00018CrossRefPubMedPubMedCentral

17.

Figueiredo A, Goh BL, Jenkins S et al (2010) Clinical practice guidelines for peritoneal access. Perit Dial Int 30:424–429. https://doi.org/10.3747/pdi.2010.00087CrossRefPubMed

18.

Nakayama M, Miyazaki M, Honda K et al (2014) Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Perit Dial Int 34:766–774. https://doi.org/10.3747/pdi.2013.00074CrossRefPubMedPubMedCentral

19.

Kolesnyk I, Dekker FW, Boeschoten EW, Krediet RT (2010) Time-dependent reasons for peritoneal dialysis technique failure and mortality. Perit Dial Int 30:170–177. https://doi.org/10.3747/pdi.2008.00277CrossRefPubMed

20.

Chidambaram M, Bargman JM, Quinn RR, Austin PC, Hux JE, Laupacis A (2011) Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study. Perit Dial Int 31:565–573. https://doi.org/10.3747/pdi.2010.00096CrossRefPubMed

21.

See EJ, Johnson DW, Hawley CM et al (2018) Risk predictors and causes of technique failure within the first year of peritoneal dialysis: an Australia and New Zealand dialysis and transplant registry (ANZDATA) study. Am J Kidney Dis 72:188–197. https://doi.org/10.1053/j.ajkd.2017.10.019CrossRefPubMed

22.

Boundville N, Ullah S, Clayton P et al (2019) Differences in peritoneal dialysis technique survival between patients treated with peritoneal dialysis systems from different companies. Nephrol Dial Transplant 34:1035–1044. https://doi.org/10.1093/ndt/gfy340CrossRef

23.

Cho Y, Johnson DW (2014) Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis 64:278–289. https://doi.org/10.1053/j.ajkd.2014.02.025CrossRefPubMed

24.

Nakayama T, Uchiyama K, Washida N et al (2021) Exercise parameters predict technique survival in patients on peritoneal dialysis. Blood Purif 50:380–389. https://doi.org/10.1159/000511293CrossRefPubMed

25.

Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458. https://doi.org/10.1038/bmt.2012.244CrossRefPubMed

26.

Isla RA, Mapiye D, Swanepoel CR, Rozumyk N, Hubahib JE, Okpechi IG (2014) Continuous ambulatory peritoneal dialysis in Limpopo province, South Africa: Predictors of patient and technique survival. Perit Dial Int 34:518–525. https://doi.org/10.3747/pdi.2013.00334CrossRefPubMedPubMedCentral

27.

Descoeudres B, Koller MT, Garzoni D et al (2008) Contribution of early failure to outcome on peritoneal dialysis. Perit Dial Int 28:259–267. https://doi.org/10.1177/089686080802800312CrossRefPubMed

28.

Cueto-Manzano AM, Quintana-Piña E, Correa-Rotter R (2001) Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center. Perit Dial Int 21:148–153. https://doi.org/10.1177/089686080102100207CrossRefPubMed

29.

Chen HL, Tarng DC, Huang LH (2019) Risk factors associated with outcomes of peritoneal dialysis in Taiwan: an analysis using a competing risk model. Med (Baltim) 98:e14385. https://doi.org/10.1097/MD.0000000000014385CrossRef

30.

Shi Y, Zheng D, Zhang L et al (2017) Six-minute walk test predicts all-cause mortality and technique failure in ambulatory peritoneal dialysis patients. Nephrology (Carlton) 22:118–124. https://doi.org/10.1111/nep.12726CrossRef

31.

Matsui M, Akai Y, Samejima KI et al (2017) Prognostic value of predialysis indices for technique failure and mortality in peritoneal dialysis patients. Ther Apher Dial 21:493–499. https://doi.org/10.1111/1744-9987.12546CrossRefPubMed

32.

Murashima M, Hamano T, Abe M, Masakane I (2021) Combination of once-weekly haemodialysis with peritoneal dialysis is associated with lower mortality compared with peritoneal dialysis alone: a longitudinal study. Clin Kidney J 14:1610–1617. https://doi.org/10.1093/ckj/sfaa173CrossRefPubMed

33.

Tanaka M, Ishibashi Y, Hamasaki Y et al (2020) Bioimpedance spectroscopy-based fluid status in combined dialysis compared with hemodialysis and peritoneal dialysis: a cross-sectional study. Ther Apher Dial 24:373–379. https://doi.org/10.1111/1744-9987.13444CrossRefPubMed

34.

Wang AY (2007) The john F. Maher award recipient Lecture 2006. The “heart” of peritoneal dialysis: residual renal function. Perit Dial Int 27:116–124. https://doi.org/10.1177/089686080702700203CrossRefPubMed

35.

Ozener C, Arikan H, Karayaylali I et al (2014) The impact of diabetes mellitus on peritoneal dialysis: the Turkey multicenter clinic study. Ren Fail 36:149–153. https://doi.org/10.3109/0886022X.2013.843275CrossRefPubMed

36.

Nessim SJ, Bargman JM, Austin PC, Nisenbaum R, Jassal SV (2009) Predictors of peritonitis in patients on peritoneal dialysis: results of a large, prospective Canadian database. Clin J Am Soc Nephrol 4:1195–1200. https://doi.org/10.2215/CJN.00910209CrossRefPubMedPubMedCentral

37.

Tsai CC, Lee JJ, Liu TP, Ko WC, Wu CJ, Pan CF et al (2013) Effects of age and diabetes mellitus on clinical outcomes in patients with peritoneal dialysis-related peritonitis. Surg Infect (Larchmt) 14:540–546. https://doi.org/10.1089/sur.2012.195CrossRef

38.

Conway EL, Sellick JA, Kurtzhalts K, Mergenhagen KA (2017) Obesity and heart failure as predictors of failure in outpatient skin and soft tissue infections. Antimicrobial Agents Chemother. https://doi.org/10.1128/AAC.02389-16CrossRef

39.

Falagas ME, Kompoti M (2006) Obesity and infection. Lancet Infect Dis 6:438–446. https://doi.org/10.1016/S1473-3099(06)70523-0CrossRefPubMed

40.

Long C, Bartlett G, Macgibbon B et al (2013) The effect of obesity on antibiotic treatment failure: a historical cohort study. Pharmacoepidemiol Drug Saf 22:970–976. https://doi.org/10.1002/pds.3461CrossRef

41.

Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y (2000) Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 72:694–701. https://doi.org/10.1093/ajcn/72.3.694CrossRefPubMed

42.

Alves Junior CA, Mocellin MC, Gonçalves ECA, Silva DA, Trindade EB (2017) Anthropometric indicators as body fat discriminators in children and adolescents: a systematic review and meta-analysis. Adv Nutr 8:718–727. https://doi.org/10.3945/an.117.015446CrossRefPubMedPubMedCentral

Titel: High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related infection in Japanese patients undergoing peritoneal dialysis
verfasst von: Eriko Yoshida Hama
Kiyotaka Uchiyama
Tomoki Nagasaka
Ei Kusahana
Takashin Nakayama
Itaru Yasuda
Kohkichi Morimoto
Naoki Washida
Hiroshi Itoh
Publikationsdatum: 27.06.2022
Verlag: Springer Netherlands
Erschienen in: International Urology and Nephrology / Ausgabe 12/2022
Print ISSN: 0301-1623
Elektronische ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-022-03252-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related infection in Japanese patients undergoing peritoneal dialysis